Investing.com - Bausch + Lomb reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Bausch + Lomb announced earnings per share of $0.31 on revenue of $942M. Analysts polled by Investing.com EPS of $0.23 on revenue of $951.5M.
Bausch + Lomb 's are down 20% and is trading at $14.25 , still down 28.96% from its 52 week high of $20.20 set on Friday, May 6, 2022.
Bausch + Lomb shares lost 0.70% to trade at $14.25 in pre-market trade the report.
Bausch + Lomb follows other major Healthcare sector earnings this month
Bausch + Lomb's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar